Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19
J Infect
.
2021 Jun;82(6):e27-e28.
doi: 10.1016/j.jinf.2021.03.006.
Epub 2021 Mar 15.
Authors
Manuel Lorenzo López Reboiro
1
,
Rebeca Suárez Fuentetaja
1
,
Raquel Gutiérrez López
1
,
Beatriz Ares Castro-Conde
1
,
Cristina Sardiña González
1
,
Inés Navarro Menéndez
2
,
Marco Francisco Pereyra Barrionuevo
3
,
M Teresa Alves Pérez
4
,
José López Castro
5
Affiliations
1
Department of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
2
Hematology Section, Department of Internal Medicine, Hospital Público de Monforte, Lugo,Spain.
3
Section of Pneumology, Department of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
4
Biostatistics, NECOM, University of Vigo, Vigo, Spain.
5
Department of Internal Medicine, Hospital Público de Monforte, Lugo, Spain. Electronic address: jlcastro126@hotmail.com.
PMID:
33737115
PMCID:
PMC7959681
DOI:
10.1016/j.jinf.2021.03.006
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Lupus Coagulation Inhibitor
SARS-CoV-2
von Willebrand Factor*
Substances
Lupus Coagulation Inhibitor
von Willebrand Factor